Table 7.

Cumulative Survival by Breast Implant

Breast Implants	FU (mo)	N	n	Survival Rate
BellaGel/BellaGel SmoothFine (n = 182)	8	95	1	0.990 ± 0.011 (0.969–1.000)
Mentor CPG (n = 159)	7	64	1	0.984 ± 0.016 (0.954–1.000)
	10	44	1	0.962 ± 0.027 (0.911–1.000)
	15	20	2	0.866 ± 0.069 (0.741–1.000)
	17	15	1	0.808 ± 0.085 (0.657–0.993)
Motiva Ergonomix (n = 152)	2	150	1	0.993 ± 0.007 (0.980–1.000)
	6	73	1	0.980 ± 0.015 (0.951–1.000)
	7	54	2	0.943 ± 0.029 (0.888–1.000)
	8	44	2	0.901 ± 0.041 (0.824–0.984)
	11	30	2	0.841 ± 0.056 (0.738–0.957)
	15	16	1	0.788 ± 0.073 (0.657–0.945)
	24	4	1	0.591 ± 0.179 (0.326–1.000)
Matrix (n = 135)	5	91	1	0.989 ± 0.011 (0.968–1.000)
	6	66	3	0.944 ± 0.027 (0.892–0.999)
	12	24	1	0.905 ± 0.047 (0.818–1.000)
	15	14	2	0.775 ± 0.094 (0.612–0.982)
Naturgel (n = 61)	2	60	1	0.983 ± 0.017 (0.951–1.000)
	6	25	1	0.944 ± 0.042 (0.866–1.000)
Natrelle 410/510 (n = 20)	10	4	1	0.750 ± 0.217 (0.426–1.000)

Values are represented as mean ± standard error with 95% CI or the number of patients, where appropriate.

FU, time points of follow-up; N, number of risks; n, incidence of postoperative complications.